Cited by 1,743Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesNF-κB Signaling Pathways

The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.

STATs in oncogenesis

Bowman, Tammy, Garcia, Roy, Turkson, James, Jove, Richard·2000·Oncogene

DOI 10.1038/sj.onc.1203527

Open this paper in CoChat — free account

Abstract

Since their discovery as key mediators of cytokine signaling, considerable progress has been made in defining the structure-function relationships of Signal Transducers and Activators of Transcription (STATs). In addition to their central roles in normal cell signaling, recent studies have demonstrated that diverse oncoproteins can activate specific STATs (particularly Stat3 and Stat5) and that constitutively-activated STAT signaling directly contributes to oncogenesis. Furthermore, extensive surveys of primary tumors and cell lines derived from tumors indicate that inappropriate activation of specific STATs occurs with surprisingly high frequency in a wide variety of human cancers. Together, these findings provide compelling evidence that aberrant STAT activation associated with oncogenesis is not merely adventitious but instead contributes to the process of malignant transformation. These studies are beginning to reveal the molecular mechanisms leading to STAT activation in the context of oncogenesis, and candidate genes regulated by STATs that may contribute to oncogenesis are being identified. Recent studies suggest that activated STAT signaling participates in oncogenesis by stimulating cell proliferation and preventing apoptosis. This review presents the evidence for critical roles of STATs in oncogenesis and discusses the potential for development of novel cancer therapies based on mechanistic understanding of STAT signaling. Oncogene (2000).

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1203527

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656

Show all 152 references

Research works printed but not linked: 7

Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . 1996 Blood 87: 1692–1697 · DOI
Hallek M, Leif Bergsagel P and Anderson KC . 1998 Blood 91: 3–21 · DOI
Ho JM, Beattie BK, Squire JA, Frank DA and Barber DL . 1999 Blood 93: 4354–4364 · DOI
Liu RY, Fan C, Garcia R, Jove R and Zuckerman KS . 1999 Blood 93: 2369–2379 · DOI
Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B and Calabretta B . 1998 Blood 91: 406–418 · DOI
Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC and Rosen ST . 1998 Blood 91: 570–576 · DOI
Wang YH, Wharton W, Garcia R, Kraker A, Jove R and Pledger WJ . 2000 Oncogene in press

Sorted by citations

Items 801–900 of 999

Caffeic Acid Inhibits Chronic UVB ‐Induced Cellular Proliferation Through JAK ‐ STAT 3 Signaling in Mouse Skin
Balupillai, A., Prasad, N. R., Kanimozhi, G., Karthikeyan, R., Muthusamy, G., Shanmugam, M., Velmurugan, D., & Ananthakrishnan, D. (2016) · Photochemistry and Photobiology · doi:10.1111/php.12588 · Cited by 45
Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway
Kim, D.-H., Park, J. E., Chae, I. G., Park, G., Lee, S., & Chun, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5677 · Cited by 43
The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer
Jiang, W., Zhao, S., Xu, L., Lu, Y., Lu, Z., Chen, C., Ni, J., Wan, R., & Yang, L. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.05.020 · Cited by 44
JAK kinases overexpression promotes in vitro cell transformation
Knoops, L., Hornakova, T., Royer, Y., Constantinescu, S. N., & Renauld, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210800 · Cited by 44
Swimming Exercise Prevents Fibrogenesis in Chronic Kidney Disease by Inhibiting the Myofibroblast Transdifferentiation
Peng, C.-C., Chen, K., Hsieh, C.-L., & Peng, R. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037388 · Cited by 43
Differential Role of Janus Family Kinases (JAKs) in Interferon-γ–Induced Lung Epithelial ICAM-1 Expression: Involving Protein Interactions between JAKs, Phospholipase Cγ, c-Src, and STAT1
Chang, Y., Holtzman, M. J., & Chen, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.589 · Cited by 44
MRTF-A and STAT3 synergistically promote breast cancer cell migration
Liao, X., Wang, N., Liu, L., Li, Z., Xing, W., Zhao, D., Sun, X., Hu, P., Dong, J., & Zhang, T. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.023 · Cited by 47
Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients
Sterlacci, W., Fiegl, M., Hilbe, W., Jamnig, H., Oberaigner, W., Schmid, T. A., Augustin, F., Auberger, J., Obermann, E. C., & Tzankov, A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181e77efc · Cited by 43
Down-Regulation of Stat3 Decreases Invasion Activity and Induces Apoptosis of Human Glioma Cells
Chen, F., Xu, Y.-M., Luo, Y., Zheng, D., Song, Y., Yu, K., Li, H., Zhang, L., Zhong, W., & Ji, Y. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9323-3 · Cited by 43
Sensitization of Head and Neck Cancer to Cisplatin Through the Use of a Novel Curcumin Analog
Abuzeid, W. M., Davis, S. J., Tang, A. L., Saunders, L. M., Brenner, J. C., Lin, J., Fuchs, J. R., Light, E., Bradford, C. R., Prince, M. E., et al. (2011) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archoto.2011.63 · Cited by 44
Ginkgetin Blocks Constitutive STAT3 Activation and Induces Apoptosis through Induction of SHP‐1 and PTEN Tyrosine Phosphatases
Baek, S. H., Lee, J. H., Ko, J., Lee, H., Nam, D., Lee, S., Yang, W. M., Um, J., Lee, J., Kim, S., et al. (2016) · Phytotherapy Research · doi:10.1002/ptr.5557 · Cited by 44
Chemotherapeutic effects of luteolin on radio-sensitivity enhancement and interleukin-6/signal transducer and activator of transcription 3 signaling repression of oral cancer stem cells
Tu, D., Lin, W., Yu, C., Lee, S., Peng, C., Lin, T., & Yu, C. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.08.009 · Cited by 43
Influence of node abundance on signaling network state and dynamics analyzed by mass cytometry
Lun, X., Zanotelli, V. R., Wade, J. D., Schapiro, D., Tognetti, M., Dobberstein, N., & Bodenmiller, B. (2017) · Nature Biotechnology · doi:10.1038/nbt.3770 · Cited by 41
A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells
Shen, W., Chen, C., Guan, Y., Song, X., Jin, Y., Wang, J., Hu, Y., Xin, T., Jiang, Q., & Li, Z. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.06.078 · Cited by 43
Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1
Liu, Y.-S., Hsu, J. H., Lin, H., Lai, S., Huang, B., Tsai, C., & Lu, D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.033 · Cited by 43
Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:lysine 1:2 in breast, pancreatic and colorectal cancer cell lines
Silva, C., Correia‐Branco, A., Andrade, N., Ferreira, A. C., Soares, M. L., Sonveaux, P., Stéphenne, J., & Martel, F. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172533 · Cited by 42
Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell–cell adhesion complexes
Rivat, C., Wever, O. D., Bruyneel, E. A., Mareel, M. M. K., Gespach, C. P., & Attoub, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207437 · Cited by 42
STAT6 expression in glioblastoma promotes invasive growth
Merk, B. C., Owens, J. L., Lopes, M.-B. S., Silva, C. M., & Hussaini, I. M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-184 · Cited by 43
Overexpression of STAT3 in HPV-mediated cervical cancer in a North Indian population
Sobti, R. C., Singh, N., Hussain, S., Suri, V., Bharti, A. C., & Das, B. C. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0133-2 · Cited by 42
Epstein-Barr virus-derived EBNA2 regulates STAT3 activation
Muromoto, R., Ikeda, O., Okabe, K., Togi, S., Kamitani, S., Fujimuro, M., Harada, S., Oritani, K., & Matsuda, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.053 · Cited by 42
c-Jun NH2-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt
Miyazaki, T., Bub, J. D., & Iwamoto, Y. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.005 · Cited by 41
Knockdown of the co-chaperone Hop promotes extranuclear accumulation of Stat3 in mouse embryonic stem cells
Longshaw, V. M., Baxter, M. A., Prewitz, M. C., & Blatch, G. L. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.09.003 · Cited by 42
Evolving role of Sorafenib in the management of hepatocellular carcinoma
Ziogas, I. A., & Tsoulfas, G. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i3.203 · Cited by 44
Dsg2 via Src-mediated transactivation shapes EGFR signaling towards cell adhesion
Ungewiß, H., Rötzer, V., Meir, M., Fey, C., Diefenbacher, M. E., Schlegel, N., & Waschke, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2869-x · Cited by 43
LncRNA MIR22HG Abrogation Inhibits Proliferation and Induces Apoptosis in Esophageal Adenocarcinoma Cells Via Activation of the STAT3/c-Myc/FAK Signaling
Su, W., Guo, C., Wang, L., Wang, Z., Yang, X., Niu, F., Tzou, D., Yang, X. Y., Huang, X., Wu, J., et al. (2018) · Aging · doi:10.18632/aging.102071 · Cited by 42
Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells
Lin (2010) · International Journal of Oncology · doi:10.3892/ijo_00000848 · Cited by 43
Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
Habib, A. A., Chun, S. J., Neel, B. G., & Vartanian, T. K. (2003) · PubMed · Cited by 42
The signal transduction networks required for phosphorylation of STAT1 at Ser727 in mouse epidermal JB6 cells in the UVB response and inhibitory mechanisms of tea polyphenols
Zykova, T. A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh334 · Cited by 42
Signal transducer and activator of transcription-3 and breast cancer prognosis.
Sato, T., Neilson, L. M., Peck, A. R., Liu, C., Tran, T. H., Witkiewicz, A., Hyslop, T., Nevalainen, M. T., Sauter, G., & Rui, H. (2011) · PubMed Central · Cited by 41
NSC 74859‐mediated inhibition of STAT 3 enhances the anti‐proliferative activity of cetuximab in hepatocellular carcinoma
Chen, W., Shen, X., Xia, X., Xu, G., Ma, T., Bai, X., & Liang, T. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02631.x · Cited by 41
Structure−Affinity Relationships of Glutamine Mimics Incorporated into Phosphopeptides Targeted to the SH2 Domain of Signal Transducer and Activator of Transcription 3
Mandal, P. K., Ren, Z., Chen, X., Xiong, C., & McMurray, J. S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901105k · Cited by 41
Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer
SCHOPPMANN, S. F., Jesch, B., Friedrich, J., Jomrich, G., Maroske, F., & Birner, P. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9475-3 · Cited by 41
Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells
Shimizu, M., Suzui, M., Deguchi, A., Lim, J. T. E., & Weinstein, I. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0714-3 · Cited by 41
A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells
Zhao, C., Wang, W., Yu, W., Jou, D., Wang, Y., Ma, H., Xiao, H., Qin, H., Zhang, C., Lü, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7338 · Cited by 42
Blockage of STAT3 Signaling Pathway by Morusin Induces Apoptosis and Inhibits Invasion in Human Pancreatic Tumor Cells
Kim, C., Kim, J. H., Oh, E. Y., Nam, D., Lee, S., Lee, J., Kim, S., Shim, B. S., & Ahn, K. S. (2015) · Pancreas · doi:10.1097/mpa.0000000000000496 · Cited by 41
Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway
Xu, D.-D., Zhou, P.-J., Wang, Y., Zhang, L., Fu, W.-Y., Ruan, B.-B., Hu, C.-Z., Hu, C.-Z., Tian, L., Qin, J., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0521-7 · Cited by 41
Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment
Adinew, G. M., Taka, E., Mochona, B., Badisa, R. B., MAZZIO, E. A., Elhag, R. I., & Soliman, K. F. A. (2021) · Nutrients · doi:10.3390/nu14010079 · Cited by 42
Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated −7 (mda-7)/interleukin-24 (IL-24) gene
Saito, Y., Miyahara, R., Gopalan, B., Litvak, A. M., Inoue, S., Shanker, M., Branch, C. D., Mhashilkar, A. M., Roth, J. A., Chada, S., et al. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700780 · Cited by 41
Prognostic Value of Signal Transducers and Activators of Transcription 3 in Breast Cancer
Sheen‐Chen, S., Huang, C.-C., Tang, R., Chou, F., & Eng, H.-L. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0089 · Cited by 41
Inhibition of cytokine‐induced JAK‐STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid
Chen, C., Chao, Y., Chang, Y., Hsu, M., & Lin, W. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704955 · Cited by 41
STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells
Yu, C.-Y., Wang, L., Khaletskiy, A., Farrar, W. L., Larner, A. C., Colburn, N. H., & Li, J. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205499 · Cited by 41
A Ras Homologue Member I Directly Inhibits Signal Transducers and Activators of Transcription 3 Translocation and Activity in Human Breast and Ovarian Cancer Cells
Nishimoto, A., Yu, Y., Lü, Z., Mao, X., Ren, Z., Watowich, S. S., Mills, G. B., Liao, W. S. ‐., Chen, X., Bast, R. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0130 · Cited by 41
Transcription Protein STAT1: Biology and Relation to Cancer
Adámková, L., Součková, K., & Kovařík, J. (2007) · Folia Biologica · doi:10.14712/fb2007053010001 · Cited by 41
Opposing effects of PML and PML/RARα on STAT3 activity
Kawasaki, A., Matsumura, I., Kataoka, Y., Takigawa, E., Nakajima, K., & Kanakura, Y. (2003) · Blood · doi:10.1182/blood-2002-08-2474 · Cited by 41
Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6–independent phenotype by murine plasmacytomas and hybridomas
Rawat, R., Rainey, G. J., Thompson, C. D., Frazier-Jessen, M. R., Brown, R. T., & Nordan, R. P. (2000) · Blood · doi:10.1182/blood.v96.10.3514 · Cited by 40
Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers
Rossi, E. A., Rossi, D. L., Cardillo, T. M., Stein, R., Goldenberg, D. M., & Chang, C. (2011) · Blood · doi:10.1182/blood-2011-03-343145 · Cited by 40
The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation
Muromoto, R., Taira, N., Ikeda, O., Shiga, K., Kamitani, S., Togi, S., Kawakami, S., Sekine, Y., Nanbo, A., Oritani, K., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.127 · Cited by 40
Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCC
Anderson, K., Ryan, N. M., Volpedo, G., Varikuti, S., Satoskar, A. R., & Oghumu, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03095 · Cited by 39
Moonlighting Proteins Are Important Players in Cancer Immunology
Adamo, A., Frusteri, C., Pallotta, M. T., Pirali, T., Sartoris, S., & Ugel, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613069 · Cited by 41
STAT92E is a positive regulator of Drosophila inhibitor of apoptosis 1 (DIAP/1) and protects against radiation-induced apoptosis
Betz, A., Ryoo, H. D., Steller, H., & Darnell, J. E., Jr. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806291105 · Cited by 40
In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients
Konjević, G. M., Martinović, K. M., Vuletić, A. M., & Babović, N. L. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e32833e3286 · Cited by 40
Signal Transduction by Human Herpesvirus 8 Viral Interleukin-6 (vIL-6) IsModulated by the Nonsignaling gp80 Subunit of the IL-6 Receptor Complex and Is Distinct from Signaling Induced by Human IL-6
Hu, F., & Nicholas, J. (2006) · Journal of Virology · doi:10.1128/jvi.00767-06 · Cited by 41
Immune manipulation of advanced breast cancer: An interpretative model of the relationship between immune system and tumor cell biology
Nicolini, A., & Carpi, A. (2008) · Medicinal Research Reviews · doi:10.1002/med.20143 · Cited by 41
Unphosphorylated STAT1 represses apoptosis in macrophages during Mycobacterium t uberculosis infection
Yao, K., Chen, Q., Wu, Y., Liu, F., Chen, X., & Zhang, Y. (2017) · Journal of Cell Science · doi:10.1242/jcs.200659 · Cited by 40
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer
Sarries, C., Haura, E. B., Roig, B., Tarón, M., Abad, A., Scagliotti, G. V., & Rosell, R. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.6.763 · Cited by 40
STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer
Fleming, J. D., Giresi, P. G., Lindahl-Allen, M., Krall, E. B., Lieb, J. D., & Struhl, K. (2015) · Epigenetics & Chromatin · doi:10.1186/1756-8935-8-7 · Cited by 39
The molecular mechanisms underlying anti‐inflammatory effects of galangin in different diseases
Hassanein, E. H. M., El‐Maksoud, M. S. A., Ibrahim, I. M., Abd‐alhameed, E. K., Althagafy, H. S., Mohamed, N. M., & Ross, S. A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7874 · Cited by 42
The Role of STAT3 in Thyroid Cancer
Sosonkina, N., Starenki, D., & Park, J. (2014) · Cancers · doi:10.3390/cancers6010526 · Cited by 41
Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells
Mantaj, J., Rahman, S. M. A., Bokshi, B., Hasan, C. M., Jackson, P. J., Parsons, R. B., & Rahman, K. M. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00052a · Cited by 39
Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib
Derenzini, E., & Younes, A. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.775244 · Cited by 39
S-glutathionylation exerts opposing roles in the regulation of STAT1 and STAT3 signaling in reactive microglia
Butturini, E., Cozzolino, F., Boriero, D., de Prati, A. C., Monti, M., Rossin, M., Canetti, D., Cellini, B., Pucci, P., & Mariotto, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.02.005 · Cited by 39
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
Karim, M. E., Tha, K. K., Othman, I., Uddin, M. B., & Chowdhury, E. H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020065 · Cited by 40
The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2
Xiao, M., Xie, J., Wu, Y., Wang, G., Qi, X., Liu, Z., Wang, Y., Wang, X., Hoque, A., Oakhill, J. S., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0528-y · Cited by 39
Flavones: Six Selected Flavones and Their Related Signaling Pathways That Induce Apoptosis in Cancer
Jeong, S. H., Kim, H. H., Ha, S. E., Park, M. Y., Bhosale, P. B., Abusaliya, A., Park, K., Heo, J., Kim, H. W., & Kim, G. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810965 · Cited by 40
Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis
Sobti, R. C., Singh, N., Hussain, S., Suri, V., Bharadwaj, M., & Das, B. C. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799891003786218 · Cited by 39
Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells
Premkumar, D. R., Jane, E. P., & Pollack, I. F. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.987548 · Cited by 39
Multiple signal transducers and activators of transcription are induced by EBV LMP-1
Zhang, L., Hong, K., Zhang, J., & Pagano, J. S. (2004) · Virology · doi:10.1016/j.virol.2004.03.007 · Cited by 40
Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells
Svensson, E., Vidovic, K., Lassen, C., Richter, J., Olofsson, T., Fioretos, T., & Gullberg, U. (2007) · Leukemia · doi:10.1038/sj.leu.2404924 · Cited by 39
Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling
Fu, Q., Jiang, Y., Zhang, D., Liu, X., Guo, J., & Zhao, J. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2746-6 · Cited by 39
Short-type PB-cadherin promotes survival of gonocytes and activates JAK-STAT signalling
Wu, J., Jester, W. F., & Orth, J. M. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.05.042 · Cited by 39
Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma
Lai, R., Rassidakis, G. Z., LIN, Q., Atwell, C., Medeiros, L. J., & Amin, H. M. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.07.011 · Cited by 42
Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges
Bansal, I., Pandey, A. K., & Ruwali, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1244597 · Cited by 41
Comparisons of the Efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF Signaling Inhibitor (Cediranib) and Sham Treatments in Mouse Tumors Using DCE-MRI, DW-MRI, and Histology
Loveless, M. E., Lawson, D., Collins, M. P., Nadella, M. V. P., Reimer, C., Huszar, D., Halliday, J. L., Waterton, J. C., Gore, J. C., & Yankeelov, T. E. (2012) · Neoplasia · doi:10.1593/neo.111478 · Cited by 38
Modulation of Host Cell Gene Expression through Activation of STAT Transcription Factors by Pasteurella multocida Toxin
Orth, J. H. C., Aktories, K., & Kubatzky, K. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609018200 · Cited by 38
Genetics of breast cancer bone metastasis: a sequential multistep pattern
Fazilaty, H., & Mehdipour, P. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9642-9 · Cited by 36
Inhibiting Aberrant Signal Transducer and Activator of Transcription Protein Activation with Tetrapodal, Small Molecule Src Homology 2 Domain Binders: Promising Agents against Multiple Myeloma
Page, B. D. G., Croucher, D. C., Li, Z., Haftchenary, S., Jimenez-Zepeda, V. H., Atkinson, J. M., Spagnuolo, P. A., Wong, Y. L., Colaguori, R., Lewis, A. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017255 · Cited by 38
Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Okamoto, T., Inozume, T., Mitsui, H., Kanzaki, M., Harada, K., Shibagaki, N., & Shimada, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1147 · Cited by 38
Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells
Kabeer, F. A., Rajalekshmi, D. S., Nair, M. S., & Remani, P. (2017) · Integrative Medicine Research · doi:10.1016/j.imr.2017.03.004 · Cited by 38
Elevated Activity of STAT3C due to Higher DNA Binding Affinity of Phosphotyrosine Dimer Rather than Covalent Dimer Formation
Li, L., & Shaw, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606940200 · Cited by 38
Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells.
Kazansky, A. V., & Rosen, J. M. (2001) · PubMed · Cited by 38
Synergistic Action of Prolactin (PRL) and Androgen on PRL-Inducible Protein Gene Expression in Human Breast Cancer Cells: A Unique Model for Functional Cooperation between Signal Transducer and Activator of Transcription-5 and Androgen Receptor
Carsol, J.-L., Gingras, S., & Simard, J. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.7.0875 · Cited by 37
Activation of Tyk2 and Stat3 Is Required for the Apoptotic Actions of Interferon-β in Primary Pro-B Cells
Gamero, A. M., Potla, R., Węgrzyn, J., Szelag, M., Edling, A. E., Shimoda, K., Link, D. C., Dulak, J., Baker, D. P., Tanabe, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509516200 · Cited by 38
The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells
Monni, R., Santos, S. C. R., Mauchauffé, M., Berger, R., Ghysdael, J., Gouilleux, F., Gisselbrecht, S., Bernard, O., & Penard‐Lacronique, V. (2001) · Oncogene · doi:10.1038/sj.onc.1204201 · Cited by 38
Synergistic mediation of tumor signaling pathways in hepatocellular carcinoma therapy via dual-drug-loaded pH-responsive electrospun fibrous scaffolds
Yuan, Z., Zhao, X., Zhao, J., Pan, G., Qiu, W., Wang, X., Zhu, Y., Zheng, Q., & Cui, W. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00206k · Cited by 38
Activated STAT3 in Choroidal Neovascular Membranes of Patients with Age-Related Macular Degeneration
Fasler‐Kan, E., Wunderlich, K., Hildebrand, P., Flammer, J., & Meyer, P. (2005) · Ophthalmologica · doi:10.1159/000085730 · Cited by 37
Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein
Shahani, V. M., Yue, P., Fletcher, S., Sharmeen, S., Sukhai, M. A., Luu, D. P., Zhang, X., Sun, H., Zhao, W. M., Schimmer, A. D., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.010 · Cited by 37
Self-citation
STAT3‐Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy
Yeh, J., & Frank, D. A. (2015) · ChemMedChem · doi:10.1002/cmdc.201500482 · Cited by 37
Programmed cell senescence: role of IL-6 in the pituitary
Sapochnik, M., Fuertes, M., & ARZT, E. S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0026 · Cited by 42
Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
Yu, X., He, L., Cao, P., & Yu, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128406 · Cited by 39
SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling
Zhou, Z., Zhang, Z., Chen, H., Bao, W., Kuang, X., Zhou, P., Gao, Z., Li, D., Xie, X., Yang, C., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01794-7 · Cited by 40
Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications
Nengroo, M. A., Verma, A., & Datta, D. B. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155916 · Cited by 39
Involvement of STAP‐2 in Brk‐mediated phosphorylation and activation of STAT5 in breast cancer cells
Ikeda, O., Mizushima, A., Sekine, Y., Yamamoto, C., Muromoto, R., Nanbo, A., Oritani, K., Yoshimura, A., & Matsuda, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01842.x · Cited by 37
STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species
Du, W., Wang, Y., Hong, J., Su, W., Lin, Y., Lu, R., Xiong, H., & Fang, J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22977 · Cited by 37
Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma
Kotipatruni, R. P., Nalla, A. K., Asuthkar, S., Gondi, C. S., Dinh, D. H., & Rao, J. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044798 · Cited by 38
Subcellular Mislocalization of Mutant Hepatitis B X Proteins Contributes to Modulation of STAT/SOCS Signaling in Hepatocellular Carcinoma
Bock, C. –., Toàn, N. L., Koeberlein, B., Song, L. H., Chin, R. A. D., Zentgraf, H., Kandolf, R., & Torresi, J. (2008) · Intervirology · doi:10.1159/000209672 · Cited by 37
STAT5 contributes to antiapoptosis in melanoma
Hassel, J. C., Winnemöller, D., Schartl, M., & Wellbrock, C. (2008) · Melanoma Research · doi:10.1097/cmr.0b013e32830ce7d7 · Cited by 37
Role of Stat3 in Skin Carcinogenesis: Insights Gained from Relevant Mouse Models
Macias, E., Rao, D., & DiGiovanni, J. (2013) · Journal of Skin Cancer · doi:10.1155/2013/684050 · Cited by 40
Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation
Sexl, V., Kovačic, B., Piekorz, R. P., Moriggl, R., Stoiber, D., Hoffmeyer, A., Liebminger, R., Kudlacek, O., Weisz, E., Rothammer, K., et al. (2003) · Blood · doi:10.1182/blood-2001-11-0142 · Cited by 37
Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.
Huether, A., Höpfner, M., Sutter, A. P., Baradari, V., Schuppan, D., & Scherübl, H. (2006) · Europe PMC (PubMed Central) · doi:10.3748/wjg.v12.i32.5160 · Cited by 37
Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma
Yu, M. O., Park, K.-J., Park, D., Chung, Y.-G., Chi, S.-G., & Kang, S.-H. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1889-8 · Cited by 37

Authors: Bowman, T., Garcia, R., Turkson, J., & Jove, R.
Affiliations: Moffitt Cancer Center (US)
University of South Florida (US)
ORCID: Turkson, James
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2000-05-25
Volume: 19
Issue: 21
Pages: 2474-2488
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1203527
OpenAlex: W2024282024
Cited by: 1,743
References: 152
Citations by year: 2026: 16 · 2025: 18 · 2024: 18 · 2023: 22 · 2022: 39 · 2021: 48 · 2020: 44 · 2019: 45 · 2018: 59 · 2017: 63 · 2016: 58 · 2015: 104 · 2014: 80 · 2013: 82 · 2012: 89
FWCI: 7.25
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: STAT, signal transducer and activator of transcription, carcinogenesis, STAT3, STAT5, malignant transformation, cytokine signaling, cell proliferation, apoptosis, cancer therapy targets, cancer cell lines
MeSH terms: Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Neoplasms, Phosphorylation, Phosphoserine, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Neoplastic, STAT1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STATs in oncogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks